Last reviewed · How we verify
Medical therapy group
At a glance
| Generic name | Medical therapy group |
|---|---|
| Also known as | oral contraceptive pills, Mirena intrauterine device, Optimal medical therapy, Guideline- driven medical therapy, Standard of Care (SOC), Medical |
| Sponsor | Yonsei University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Conservative Treatment of Trigger Finger (NA)
- Bedside Bike Early Mobilization Program for Inpatients (NA)
- Ablation Versus Medical Management of Atrial Fibrillation in HFpEF (NA)
- New York Better Breathing Study (NA)
- Alesis OSA-1 Obstructive Sleep Apnea Treatment (NA)
- Exercise for the Treatment of Cancer-Related Sarcopenia (NA)
- Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment (PHASE1, PHASE2)
- KD Treatment for Super-refractory Status Epilepticus (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medical therapy group CI brief — competitive landscape report
- Medical therapy group updates RSS · CI watch RSS
- Yonsei University portfolio CI